BR0107216A - Compostos estroprogestacionais tópicos com efeito sistêmico - Google Patents
Compostos estroprogestacionais tópicos com efeito sistêmicoInfo
- Publication number
- BR0107216A BR0107216A BR0107216-1A BR0107216A BR0107216A BR 0107216 A BR0107216 A BR 0107216A BR 0107216 A BR0107216 A BR 0107216A BR 0107216 A BR0107216 A BR 0107216A
- Authority
- BR
- Brazil
- Prior art keywords
- topical
- systemic
- compounds
- agent
- hormonal
- Prior art date
Links
- 230000009885 systemic effect Effects 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000699 topical effect Effects 0.000 title abstract 3
- 230000003054 hormonal effect Effects 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- NVUUMOOKVFONOM-GPBSYSOESA-N 19-Norprogesterone Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 NVUUMOOKVFONOM-GPBSYSOESA-N 0.000 abstract 1
- 201000000736 Amenorrhea Diseases 0.000 abstract 1
- 206010001928 Amenorrhoea Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 231100000540 amenorrhea Toxicity 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 230000002611 ovarian Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000001072 progestational effect Effects 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Abstract
"COMPOSTOS ESTROPROGESTACIONAIS TóPICOS COM EFEITO SISTêMICO". A presente invenção refere-se ao campo da química terapêutica, e mais particularmente, à produção de novas formas galênicas a serem aplicadas sobre a pele. Esta tem mais particularmente como objeto uma composição hormonal tópica, com efeito, sistêmico para o tratamento hormonal da perimenopausa e da menopausa, bem como para o tratamento de deficiência hormonal ovariana na mulher com amenorréia, caracterizado pelo fato de incluir, como princípios ativos, um composto progestacional derivado da 19-nor progesterona e do estradiol ou de um de seus derivados, um veículo que permite a etapa sistêmica desses princípios ativos, selecionado do grupo constituído por um agente solubilizante, um agente promotor de absorção, um agente formador de filme, um agente gelificante e suas misturas, associado ou misturado com excipientes apropriados para a realização de uma forma farmacêutica gelificada e/ou na forma de filme.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0011791A FR2814074B1 (fr) | 2000-09-15 | 2000-09-15 | Nouvelles compositions estro-progestatives topiques a effet systemique |
PCT/FR2001/002865 WO2002022132A2 (fr) | 2000-09-15 | 2001-09-14 | Nouvelles compositions estro-progestatives topiques a effet systemique |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0107216A true BR0107216A (pt) | 2002-07-09 |
Family
ID=8854345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0107216-1A BR0107216A (pt) | 2000-09-15 | 2001-09-14 | Compostos estroprogestacionais tópicos com efeito sistêmico |
Country Status (20)
Country | Link |
---|---|
US (1) | US7030104B2 (pt) |
EP (1) | EP1265617B1 (pt) |
JP (1) | JP2004508405A (pt) |
CN (1) | CN1407898A (pt) |
AT (1) | ATE330614T1 (pt) |
AU (1) | AU778889B2 (pt) |
BR (1) | BR0107216A (pt) |
CA (1) | CA2391162A1 (pt) |
CZ (1) | CZ20021691A3 (pt) |
DE (1) | DE60120931D1 (pt) |
DZ (1) | DZ3221A1 (pt) |
FR (1) | FR2814074B1 (pt) |
HK (1) | HK1054332A1 (pt) |
HU (1) | HUP0204349A3 (pt) |
IL (1) | IL149448A0 (pt) |
MA (2) | MA26834A1 (pt) |
MX (1) | MXPA02004930A (pt) |
NO (1) | NO20022292L (pt) |
WO (1) | WO2002022132A2 (pt) |
ZA (1) | ZA200203439B (pt) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US20020141970A1 (en) * | 2001-03-05 | 2002-10-03 | Pettit Dean K. | Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
TW200404548A (en) * | 2002-06-25 | 2004-04-01 | Wyeth Corp | Pharmaceutical composition containing cyclothiocarbamate derivatives in treatment of hormone-related conditions |
FR2848112B1 (fr) * | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
AU2003296810A1 (en) * | 2002-12-10 | 2004-07-09 | Besins International Belgique | Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
FR2851470B1 (fr) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
PT1670433E (pt) | 2003-10-10 | 2012-02-08 | Ferring Bv | Fórmula farmacológica transdérmica para a minimização de resíduos na pele |
US7425340B2 (en) * | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
JP4705343B2 (ja) * | 2004-07-09 | 2011-06-22 | 日東電工株式会社 | 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤 |
CN101107015B (zh) * | 2005-01-19 | 2013-01-23 | 日本全药工业株式会社 | 乳腺炎用注入剂 |
US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
US10016442B2 (en) * | 2005-06-16 | 2018-07-10 | Allergan Pharmaceuticals International Limited | Estrogen compositions for vaginal administration |
WO2006138715A1 (en) * | 2005-06-16 | 2006-12-28 | Warner Chilcott Company, Inc. | Estrogen compositions for vaginal administration |
CN101232869B (zh) * | 2005-06-16 | 2016-03-02 | 沃纳奇尔科特有限责任公司 | 局部给药的凝胶组合物 |
SI1937276T1 (sl) | 2005-10-12 | 2013-04-30 | Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road | Izboljšani testosteronski gel in postopek uporabe |
US20070254036A1 (en) * | 2006-04-13 | 2007-11-01 | Besins Healthcare Sa | Treatment of menopause associated symptoms |
CA2646667C (en) | 2006-04-21 | 2014-03-11 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US7772213B2 (en) * | 2006-07-27 | 2010-08-10 | Nathan Strick | Composition for the treatment of inflammatory conditions |
FR2924942B1 (fr) * | 2007-12-14 | 2012-06-15 | Pf Medicament | Compositions pharmaceutiques transcutanees contenant une hormone steroidienne |
US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
CN107007611B (zh) * | 2017-06-02 | 2020-04-14 | 上海市计划生育科学研究所 | 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用 |
WO2019140087A1 (en) | 2018-01-10 | 2019-07-18 | Celista Pharmaceuticals Llc | Testosterone transdermal spray with film |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
FR2737411B1 (fr) * | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
EP0785212A1 (en) * | 1996-01-22 | 1997-07-23 | Laboratoire Theramex | New 19-nor-pregnene derivatives |
EP0785211A1 (en) * | 1996-01-22 | 1997-07-23 | Laboratoire Theramex | New substituted 19-nor-pregnane derivatives |
WO2001030355A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
WO2001030356A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
-
2000
- 2000-09-15 FR FR0011791A patent/FR2814074B1/fr not_active Expired - Fee Related
-
2001
- 2001-09-14 JP JP2002526382A patent/JP2004508405A/ja not_active Withdrawn
- 2001-09-14 CZ CZ20021691A patent/CZ20021691A3/cs unknown
- 2001-09-14 AT AT01969895T patent/ATE330614T1/de not_active IP Right Cessation
- 2001-09-14 IL IL14944801A patent/IL149448A0/xx unknown
- 2001-09-14 HU HU0204349A patent/HUP0204349A3/hu unknown
- 2001-09-14 MX MXPA02004930A patent/MXPA02004930A/es unknown
- 2001-09-14 BR BR0107216-1A patent/BR0107216A/pt not_active IP Right Cessation
- 2001-09-14 CA CA002391162A patent/CA2391162A1/fr not_active Abandoned
- 2001-09-14 DZ DZ013221A patent/DZ3221A1/fr active
- 2001-09-14 DE DE60120931T patent/DE60120931D1/de not_active Expired - Lifetime
- 2001-09-14 AU AU90026/01A patent/AU778889B2/en not_active Ceased
- 2001-09-14 US US10/129,040 patent/US7030104B2/en not_active Expired - Fee Related
- 2001-09-14 WO PCT/FR2001/002865 patent/WO2002022132A2/fr active IP Right Grant
- 2001-09-14 CN CN01803562A patent/CN1407898A/zh active Pending
- 2001-09-14 EP EP01969895A patent/EP1265617B1/fr not_active Expired - Lifetime
-
2002
- 2002-04-15 MA MA26604A patent/MA26834A1/fr unknown
- 2002-04-30 ZA ZA200203439A patent/ZA200203439B/xx unknown
- 2002-05-13 MA MA26636A patent/MA26843A1/fr unknown
- 2002-05-14 NO NO20022292A patent/NO20022292L/no unknown
-
2003
- 2003-09-16 HK HK03106658.7A patent/HK1054332A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
MA26843A1 (fr) | 2004-12-20 |
WO2002022132A2 (fr) | 2002-03-21 |
DE60120931D1 (de) | 2006-08-03 |
AU9002601A (en) | 2002-03-26 |
US7030104B2 (en) | 2006-04-18 |
US20030181430A1 (en) | 2003-09-25 |
CZ20021691A3 (cs) | 2002-10-16 |
AU778889B2 (en) | 2004-12-23 |
NO20022292D0 (no) | 2002-05-14 |
JP2004508405A (ja) | 2004-03-18 |
WO2002022132A3 (fr) | 2002-09-12 |
EP1265617B1 (fr) | 2006-06-21 |
ATE330614T1 (de) | 2006-07-15 |
CA2391162A1 (fr) | 2002-03-21 |
NO20022292L (no) | 2002-07-15 |
HUP0204349A2 (en) | 2003-05-28 |
HUP0204349A3 (en) | 2005-03-29 |
CN1407898A (zh) | 2003-04-02 |
ZA200203439B (en) | 2003-08-18 |
DZ3221A1 (fr) | 2002-03-21 |
FR2814074B1 (fr) | 2003-03-07 |
HK1054332A1 (zh) | 2003-11-28 |
FR2814074A1 (fr) | 2002-03-22 |
MA26834A1 (fr) | 2004-12-20 |
MXPA02004930A (es) | 2005-02-17 |
IL149448A0 (en) | 2002-11-10 |
EP1265617A2 (fr) | 2002-12-18 |
WO2002022132A8 (fr) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0107216A (pt) | Compostos estroprogestacionais tópicos com efeito sistêmico | |
BR112012014059B1 (pt) | Gel transdérmico de progestina / estradiol | |
US8349820B2 (en) | Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido | |
BR9909027A (pt) | Composição hormonal tópica com efeito sistêmico | |
PE20070329A1 (es) | Composiciones con estrogenos y metodos terapeuticos para su uso | |
BRPI0611443B8 (pt) | medicamento compreendendo gestágeno e/ou estrógeno e 5-metil-(6s)-tetrahidrofolato, seu uso e seu processo de formulação, e kit | |
MEP38008A (en) | Drospirenone for hormone replacement therapy | |
BR0109334A (pt) | Terapia de reposição hormonal | |
WO1997003676A1 (es) | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea | |
Kelly et al. | Iatrogenic Cushing's syndrome. | |
Chambers et al. | Antipyrine elimination in saliva after low‐dose combined or progestogen‐only oral contraceptive steroids. | |
ES2725774T1 (es) | Uso de un estrógeno en la fabricación de una composición que contiene estrógeno para el tratamiento de la vaginitis atrófica | |
AU2021104419A4 (en) | Polyherbal Gel formulation for growth of Hair Follicle | |
Odabasi et al. | A prospective randomized comparative study of the effects of intranasal and transdermal 17 β-estradiol on postmenopausal symptoms and vaginal cytology | |
Bertozzi et al. | A Sodium Hyaluronate-Based Oral Formulation as Adjuvant for Radiofrequency with Radioporation Treatment in Women with Vulvovaginal Atrophy: a Preliminary Study | |
PT1423407E (pt) | Esteroides 4-halogenados de 17-metileno, processo para a sua preparacao e composicoes farmaceuticas contendo estes compostos | |
JP2005206523A (ja) | 外用鎮痒剤 | |
Dören et al. | Therapeutic value and long-term safety of pulsed estrogen therapy | |
Teter | Treatment of endocrine impotence. | |
Marsden | Bioidentical Hormone Replacement: Guiding Principles for Practice | |
Gaster | The Porn Industry | |
Roller et al. | Acne: description, treatment, quality of life, and the role of the pharmacist. | |
CZ290745B6 (cs) | Farmaceutický přípravek na bázi transdermálního emulgelu s obsahem jednoho nebo více hormonů a způsob jeho výroby |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008. |